Showing 3201-3210 of 20429 results for "".
- Immunotherapy Approach Shows Potential in Some People With Metastatic Solid Tumorshttps://reachmd.com/news/immunotherapy-approach-shows-potential-in-some-people-with-metastatic-solid-tumors/2467340/News ReleaseThursday, July 11, 2024 Immunotherapy approach shows potential in some people with metastatic solid tumors NIH researchers achieved tumor shrinkage in three of seven patients with colorectal cancers.Early findin
- Researchers Identify Cause of Serious Brain Bleeding Condition in Premature Newbornshttps://reachmd.com/news/researchers-identify-cause-of-serious-brain-bleeding-condition-in-premature-newborns/2467294/A new study by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare, reveals insights that could lead to new treatments for a serious brain bleeding condition that’s common in newborns with very low birth weight. The findings are pu
- How Brain-Computer Interface Treatment for Strokes Is Helping Patients Recover Fasterhttps://reachmd.com/news/how-brain-computer-interface-treatment-for-strokes-is-helping-patients-recover-faster/2467297/Stroke Rehabilitation will be Shaped by the Development of Brain-Computer Interfaces Capturing both human and animal “thought” and using it for a range of purposes is not just science fiction anymore. Although brain-computer interface (BCI) has been in rese
- Doctor on How to Avoid 'World’s Most Infectious Disease’ as Cases Soar in UKhttps://reachmd.com/news/doctor-on-how-to-avoid-worlds-most-infectious-disease-as-cases-soar-in-uk/2467277/A doctor has issued crucial advice to Brits as cases of one of the world’s most infectious diseases continue to rise. Measles is seeing a resurgence not just in the UK but also on continental Europe. Measles is a viral illness which usually starts with cold-like symptoms, fo
- Fighting COVID-19 with a Cancer Drug: A New Approach to Preventing Irreversible Organ Damage in Infectious Diseaseshttps://reachmd.com/news/fighting-covid-19-with-a-cancer-drug-a-new-approach-to-preventing-irreversible-organ-damage-in-infectious-diseases/2467275/Unusually high numbers of macrophages (in brown) were detected in cross-sections of lungs from COVID-19 patients using immunohistochemical techniques. Blue counterstain detects nuclei of
- Declining Iron Levels in Women in Militaryhttps://reachmd.com/news/declining-iron-levels-in-women-in-military/2467286/After five months of basic military training, the proportion of female recruits with iron deficiency had more than doubled, from 25% to 55%. According to the researchers, this study calls for increased attention and action to improve iron levels.The study, published in the
- Researchers Identify a Novel Biomarker Linked to Renal Cancer Recurrencehttps://reachmd.com/news/researchers-identify-a-novel-biomarker-linked-to-renal-cancer-recurrence/2467278/Credit: Unsplash/CC0 Public Domain Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk
- Researchers Find a Common Immune System Mechanism Between Pregnancy and Cancerhttps://reachmd.com/news/researchers-find-a-common-immune-system-mechanism-between-pregnancy-and-cancer/2467279/Credit: Cell (2024). DOI: 10.1016/j.cell.2024.06.012 To understand why some cancers successfully circumvent the immun
- Adding Sorafenib to TACE Improves PFS, OS in Recurrent HCChttps://reachmd.com/news/adding-sorafenib-to-tace-improves-pfs-os-in-recurrent-hcc/2467330/Adding sorafenib to transarterial chemoembolization (TACE) improves outcomes in patients with recurrent, intermediate-stage hepatocellular carcinoma (HCC), according to research published in JAMA Oncology. This phase 3 trial showed that patients who
- Tricking the Brain’s Inner GPS: Grid Cells Responses to the Illusion of Self-Locationhttps://reachmd.com/news/tricking-the-brains-inner-gps-grid-cells-responses-to-the-illusion-of-self-location/2467259/Newswise — Dr. Hyuk-June Moon from the Bionics Research Center at the Korea Institute of Science and Technology (KIST), in collaboration with Prof. Olaf Blanke’s team at the Swiss Federal Institute of Technology Lausanne (EPFL